Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 4
2008 9
2009 7
2010 3
2011 3
2012 1
2013 4
2014 3
2015 2
2016 4
2017 3
2019 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
The association of statin therapy with the risk of recurrent venous thrombosis.
Smith NL, Harrington LB, Blondon M, Wiggins KL, Floyd JS, Sitlani CM, McKnight B, Larson EB, Rosendaal FR, Heckbert SR, Psaty BM. Smith NL, et al. J Thromb Haemost. 2016 Jul;14(7):1384-92. doi: 10.1111/jth.13334. Epub 2016 Jun 20. J Thromb Haemost. 2016. PMID: 27061794 Free PMC article.
Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation.
Goumidi L, Thibord F, Wiggins KL, Li-Gao R, Brown MR, van Hylckama Vlieg A, Souto JC, Soria JM, Ibrahim-Kosta M, Saut N, Daian D, Olaso R, Amouyel P, Debette S, Boland A, Bailly P, Morrison AC, Mook-Kanamori DO, Deleuze JF, Johnson A, de Vries PS, Sabater-Lleal M, Chiaroni J, Smith NL, Rosendaal FR, Chasman DI, Trégouët DA, Morange PE. Goumidi L, et al. Blood. 2021 Apr 29;137(17):2394-2402. doi: 10.1182/blood.2020008997. Blood. 2021. PMID: 33512453 Free PMC article.
Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study.
Lindström S, Germain M, Crous-Bou M, Smith EN, Morange PE, van Hylckama Vlieg A, de Haan HG, Chasman D, Ridker P, Brody J, de Andrade M, Heit JA, Tang W, DeVivo I, Grodstein F, Smith NL, Tregouet D, Kabrhel C; INVENT Consortium. Lindström S, et al. Hum Genet. 2017 Jul;136(7):897-902. doi: 10.1007/s00439-017-1811-x. Epub 2017 May 20. Hum Genet. 2017. PMID: 28528403 Free PMC article.
Cerivastatin, genetic variants, and the risk of rhabdomyolysis.
Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, Taylor KD, Rotter JI, Jaquish CE, Kwok PY, Tracy RP, Psaty BM. Marciante KD, et al. Pharmacogenet Genomics. 2011 May;21(5):280-8. doi: 10.1097/FPC.0b013e328343dd7d. Pharmacogenet Genomics. 2011. PMID: 21386754 Free PMC article.
The ENTPD1 promoter polymorphism -860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk.
Maloney JP, Branchford BR, Brodsky GL, Cosmic MS, Calabrese DW, Aquilante CL, Maloney KW, Gonzalez JR, Zhang W, Moreau KL, Wiggins KL, Smith NL, Broeckel U, Di Paola J. Maloney JP, et al. FASEB J. 2017 Jul;31(7):2771-2784. doi: 10.1096/fj.201600344R. Epub 2017 Mar 16. FASEB J. 2017. PMID: 28302652 Free PMC article.
38 results